Hematology
Conference Coverage
EHR-based thromboembolism risk tool boosted prophylaxis
A thromboembolism risk calculator in a hospital’s EHR led to a significant rise in appropriate thromboprophylaxis and a drop in thromboembolic...
News
Apixaban outmatches rivaroxaban in patients with AFib and valvular heart disease
Compared with rivaroxaban, patients who received apixaban had a 43% reduced risk of stroke or embolism.
Conference Coverage
Blood test for multiple cancers: Many false positives
“This technology is not ready for population-wide screening, but as the technology improves, costs will go down.”
News
Blood type linked to higher risk for early onset stroke
“The risk of stroke due to blood type is smaller than other risk factors that we know about, like smoking and hypertension. I would be much more...
Latest News
Leukemia rates two to three times higher in children born near fracking
“This study is among the few to focus on drinking water specifically and the first to apply a novel metric designed to capture potential exposure...
Sponsored Supplement
Cost-Effective Treatment Option for von Willebrand Disease
News
Long COVID doubles risk of some serious outcomes in children, teens
“Many of these conditions were rare or uncommon among children in this analysis, but even a small increase in these conditions is notable.”
Article
No more injections after one-off gene therapy in hemophilia B
“Normal factor IX levels can be achieved in patients with severe or moderately severe hemophilia B with the use of relatively low vector doses of...
News
Evidence still lacking that vitamins prevent CVD, cancer: USPSTF
In its final recommendation statement on the subject, the task force does, however, recommend against use of vitamin E and beta-carotene.
News
Corticosteroids may raise risk of sickle cell pain crisis
“Vaso-occlusive events and related hospitalization appear to follow corticosteroid prescription fairly quickly.”
News
Some leukemias detectable up to 16 years before diagnosis?
Sequencing analysis showed that even high-risk CLL subtypes precursor states may exist up to 16 years longer than previously thought.